Remy Analytics.
340B compliance software.

Remy Analytics is 340B compliance software that connects your EMR, claims, contract pharmacy, and GPO feeds into a single reconciled model, then runs eligibility, compliance, and revenue analytics on top of it. It is the data platform behind every Remy engagement, and it can also be deployed on its own. You get live dashboards, anomaly alerts, and audit-ready exports for your 340B program and infusion operations.

Remy Analytics automates 340B reconciliation by pulling accumulator, dispense, and purchase files from your TPA, contract pharmacies, and wholesaler on a scheduled feed, then matching them line by line against the encounter and claim records already in your EMR. Anything that does not match is written to an exception queue rather than buried in a monthly report, so your team works a list of specific records instead of comparing spreadsheets. Every exception keeps a link back to the original row in each system it came from, which is what turns a disagreement between two systems into a short lookup. Remy works that queue with your team on a standing cadence and tracks each exception through to closeout.

When you evaluate a 340B platform, the questions that separate vendors are how it reconciles data across systems, whether it can show its work on any single record, and who is accountable when a number gets challenged. Ask to see one record traced end to end, from the encounter in the EMR through the dispense and the purchase, rather than a dashboard tour. Ask which of your systems it reads natively and which need a flat file, because that is where implementation timelines slip. Remy runs evaluations against your own data rather than a sample set, and will tell you when a gap belongs to your source systems rather than to the platform.

Remy Analytics tracks every dispensing location in one model, so a covered entity running several clinics and contract pharmacies sees them side by side instead of one export at a time. Each location carries its own configuration, rules are applied per location, and results roll up into a single program view, so you can tell whether something is specific to one site or showing up everywhere. Alerts fire on the location where the pattern changed and name the records behind them. Remy configures those rules with your team against your own policies and procedures, and revisits them whenever your program or your source systems change.

Remy Analytics keeps audit-ready documentation continuously instead of assembling it after a request arrives: when the platform classifies a record, it stores the source rows and the rule configuration that produced that classification at that moment. So when someone asks why a particular dispense was treated the way it was, the supporting detail is already attached to it and timestamped. Exports are built from that stored evidence rather than reconstructed from current data, which is what keeps an answer consistent months later. Remy supports the covered entity through preparation and response; responsibility for the program itself stays with the covered entity.

Remy Analytics identifies revenue leakage by comparing what your program captured against what your own encounter, dispense, and purchase data shows was capturable, then grouping the gap by cause: location, provider, drug, payer, or the workflow step where it was lost. That turns leakage from one lump figure into a ranked list your team can work, starting with the causes that keep recurring. Remy reviews the largest categories with you, agrees which are worth fixing, and then tracks whether the fix held. We report the gap your own data shows rather than projecting a number before we have seen it.

Yes - Remy Analytics reports drug spend across your purchasing accounts and dispensing locations in one place, broken out by product, account, and site, so finance can see where spend concentrates and how it is moving. Because purchase data sits in the same reconciled model as dispense and claim data, you can look at spend next to what was captured instead of reconciling two systems by hand. Pharmacy and finance leaders use it to pressure-test a proposed change and then to see its effect once it is live. Remy supplies the reporting; clinical and formulary decisions stay with your providers and your pharmacy leadership.

No - Remy Analytics can be deployed on its own, alongside your existing 340B TPA or in-house team. Many partners start with Analytics to understand their program's leakage, then decide whether to move compliance or TPA work to Remy.

Remy Analytics has prebuilt connectors for major EMRs (Epic, Cerner, athenahealth, eClinicalWorks, NextGen), common pharmacy management systems, 340B split-billing engines (Sentry, Macro Helix, ProxsysRx), and claims clearinghouses. Flat-file and SFTP feeds are supported for legacy systems.

Most covered entities are live in 4-6 weeks. Week 1-2 covers data mapping and credentialing; week 3-4 covers eligibility rule configuration and historical reconciliation; week 5-6 is validation, training, and go-live. You get your first insights report on day 30.

Remy signs a business associate agreement (BAA) before any PHI moves. Before implementation, we walk your compliance team through how the data is secured, who can access it, and where it is hosted.

Analytics is priced as a fixed monthly platform fee scaled to encounter volume, not a percentage of savings. That keeps our incentives aligned with accuracy rather than upsell. Implementation is a separate one-time fee that's waived for Remy TPA or 340B management customers.

It depends on your program's size and where it leaks today. Most of the value comes from finding previously missed eligible scripts and fixing compliance issues sooner. We estimate the opportunity from your own data before you commit.

Yes - the platform ships with role-based dashboards for CFOs (revenue, savings, forecasts), pharmacy directors (capture rates, formulary impact), and compliance leads (audit trails, anomaly queue). Each team sees what's relevant without needing SQL or a BI analyst.